logo

Indian News

Share SHARE

Aug17-081717.jpg The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of August 17, 2017.

Slide0-Alzheimers-081717.jpg The development of Alzheimer's drugs has been marred by a high failure rate. A U.S. study, which analyzed how the Alzheimer's clinical trials fared during the period of 2002 to 2012, revealed a failure rate of 99.6% compared to a failure rate of 81% for cancer drugs.

Pharma-081717.jpg Today's Daily Dose brings you news about Acadia Healthcare's secondary offering; ARCA's progress in GENETIC-AF trial; Iovance's milestone that has boosted investor optimism; Psychemedics' role to play testing of drugs of abuse; Seattle Genetics' upcoming regulatory catalyst and inspection classification of Valeant's Bausch + Lomb manufacturing facility in Tampa, Florida.

Aug16-081617.jpg The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of August 16, 2017.

Pharma-081617.jpg Today's daily dose brings you news about patent protection of Alexion's Soliris; approval of Amicus' Fabry disease drug in Australia; mixed results from Bristol-Myers' CheckMate -214 trial; FibroGen's stock offering; ObsEva's upcoming milestones; Portola's regulatory catalyst and patent litigation related to Supernus' antieleptic drug Oxtellar XR.

Aug15-081517.jpg The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of August 15, 2017.

pharma-081517.jpg Today's Daily Dose brings you news about CEL-SCI's resumption of Multikine trial; Fate Therapeutics' progress with its pipeline; Lipocine's regulatory catalyst to watch out for; Omeros' stock offering; Ophthotech's disappointing results from wet AMD trial; Regeneron's failed respiratory syncytial virus trial and Zynerba's osteoarthritis trial results.

Pharma-081117.jpg The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of August 14, 2017.

Chefs-Warehouse-081417.jpg Shares of The Chefs' Warehouse Inc. (CHEF) are up 11% year-to-date, a tad higher than the 9% return for the S&P 500 index during the same period.

Follow RTT